The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and toxicity from phase II study of dose escalation to intraprostatic tumor nodule in localized prostate cancer.
 
Julia Murray
Honoraria - Janssen
Consulting or Advisory Role - Astellas Oncology
Speakers' Bureau - Ferring
 
Emma Alexander
No Relationships to Disclose
 
Alison Tree
Honoraria - Astellas Oncology; Bayer; Ferring; Janssen
Research Funding - Accuray; Elekta
 
Helen McNair
No Relationships to Disclose
 
Vibeke Hansen
No Relationships to Disclose
 
Annie Gao
No Relationships to Disclose
 
Karen Thomas
No Relationships to Disclose
 
Nandita M DeSouza
No Relationships to Disclose
 
David P. Dearnaley
Honoraria - Janssen; Sandoz; Takeda
Consulting or Advisory Role - Cadence Research and Consulting; FirstWord; Janssen; Janssen Research & Development; Sandoz; Takeda
Speakers' Bureau - Janssen; Janssen-Cilag
Patents, Royalties, Other Intellectual Property - Abiraterone acetate was developed at The Institute of Cancer Research, which therefore has a commercial interest in the development of this agent. Professor Dearnaley is on the Institute’s Rewards to Inventors list for abiraterone acetate. (Inst)
Expert Testimony - Vitality Life
Travel, Accommodations, Expenses - Janssen; Takeda